nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—sarcoma	0.808	1	CbGaD
Pseudoephedrine—NFATC1—periosteum—sarcoma	0.0162	0.249	CbGeAlD
Pseudoephedrine—NFATC1—mammary gland—sarcoma	0.00481	0.0739	CbGeAlD
Pseudoephedrine—NFATC1—hematopoietic system—sarcoma	0.00293	0.045	CbGeAlD
Pseudoephedrine—NFATC1—connective tissue—sarcoma	0.00282	0.0433	CbGeAlD
Pseudoephedrine—IL2—hematopoietic system—sarcoma	0.00268	0.0412	CbGeAlD
Pseudoephedrine—IL2—connective tissue—sarcoma	0.00258	0.0396	CbGeAlD
Pseudoephedrine—IL2—skin of body—sarcoma	0.00233	0.0358	CbGeAlD
Pseudoephedrine—NFATC1—lymphoid tissue—sarcoma	0.00207	0.0317	CbGeAlD
Pseudoephedrine—IL2—uterus—sarcoma	0.00203	0.0311	CbGeAlD
Pseudoephedrine—NFATC1—tendon—sarcoma	0.00194	0.0298	CbGeAlD
Pseudoephedrine—IL2—lymphoid tissue—sarcoma	0.00189	0.029	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—sarcoma	0.00188	0.0289	CbGeAlD
Pseudoephedrine—IL2—bone marrow—sarcoma	0.00172	0.0264	CbGeAlD
Pseudoephedrine—NFATC1—testis—sarcoma	0.00161	0.0247	CbGeAlD
Pseudoephedrine—IL2—liver—sarcoma	0.00139	0.0213	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—sarcoma	0.00117	0.0179	CbGeAlD
Pseudoephedrine—TNF—lymph node—sarcoma	0.00111	0.0171	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Thiotepa—sarcoma	0.00108	0.0431	CcSEcCtD
Pseudoephedrine—IL2—lymph node—sarcoma	0.00107	0.0164	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Vincristine—sarcoma	0.000957	0.0382	CcSEcCtD
Pseudoephedrine—SLC6A3—hematopoietic system—sarcoma	0.000709	0.0109	CbGeAlD
Pseudoephedrine—Delirium—Thiotepa—sarcoma	0.000694	0.0277	CcSEcCtD
Pseudoephedrine—SLC6A4—hematopoietic system—sarcoma	0.00065	0.00997	CbGeAlD
Pseudoephedrine—ADRB1—connective tissue—sarcoma	0.000647	0.00993	CbGeAlD
Pseudoephedrine—MAOA—myometrium—sarcoma	0.000614	0.00942	CbGeAlD
Pseudoephedrine—MAOA—embryo—sarcoma	0.00059	0.00906	CbGeAlD
Pseudoephedrine—MAOA—seminal vesicle—sarcoma	0.000554	0.00851	CbGeAlD
Pseudoephedrine—ADRA1A—hematopoietic system—sarcoma	0.000532	0.00816	CbGeAlD
Pseudoephedrine—MAOA—hematopoietic system—sarcoma	0.000527	0.00809	CbGeAlD
Pseudoephedrine—ADRB1—cardiac atrium—sarcoma	0.000511	0.00783	CbGeAlD
Pseudoephedrine—MAOA—connective tissue—sarcoma	0.000507	0.00778	CbGeAlD
Pseudoephedrine—ADRA2A—myometrium—sarcoma	0.000471	0.00722	CbGeAlD
Pseudoephedrine—ADRA2A—seminal vesicle—sarcoma	0.000425	0.00653	CbGeAlD
Pseudoephedrine—Urinary retention—Thiotepa—sarcoma	0.000412	0.0165	CcSEcCtD
Pseudoephedrine—ADRA2A—hematopoietic system—sarcoma	0.000404	0.0062	CbGeAlD
Pseudoephedrine—MAOA—cardiac atrium—sarcoma	0.0004	0.00614	CbGeAlD
Pseudoephedrine—MAOA—uterus—sarcoma	0.000398	0.00611	CbGeAlD
Pseudoephedrine—ADRA2A—connective tissue—sarcoma	0.000389	0.00597	CbGeAlD
Pseudoephedrine—SLC6A3—testis—sarcoma	0.000388	0.00596	CbGeAlD
Pseudoephedrine—ADRA1A—lymphoid tissue—sarcoma	0.000374	0.00574	CbGeAlD
Pseudoephedrine—Urinary retention—Vincristine—sarcoma	0.000366	0.0146	CcSEcCtD
Pseudoephedrine—Dysuria—Thiotepa—sarcoma	0.00035	0.014	CcSEcCtD
Pseudoephedrine—MAOA—tendon—sarcoma	0.000349	0.00535	CbGeAlD
Pseudoephedrine—SLC6A2—testis—sarcoma	0.000313	0.00481	CbGeAlD
Pseudoephedrine—CYP2D6—hematopoietic system—sarcoma	0.000313	0.0048	CbGeAlD
Pseudoephedrine—Dysuria—Vincristine—sarcoma	0.000311	0.0124	CcSEcCtD
Pseudoephedrine—ADRA2A—cardiac atrium—sarcoma	0.000307	0.00471	CbGeAlD
Pseudoephedrine—ADRA2A—uterus—sarcoma	0.000305	0.00469	CbGeAlD
Pseudoephedrine—Hallucination—Thiotepa—sarcoma	0.000298	0.0119	CcSEcCtD
Pseudoephedrine—MAOA—testis—sarcoma	0.000289	0.00443	CbGeAlD
Pseudoephedrine—Sweating—Vincristine—sarcoma	0.000284	0.0113	CcSEcCtD
Pseudoephedrine—Delirium—Epirubicin—sarcoma	0.00028	0.0112	CcSEcCtD
Pseudoephedrine—Sweating—Mitoxantrone—sarcoma	0.000277	0.011	CcSEcCtD
Pseudoephedrine—ADRA1A—liver—sarcoma	0.000275	0.00423	CbGeAlD
Pseudoephedrine—MAOA—liver—sarcoma	0.000273	0.00419	CbGeAlD
Pseudoephedrine—Arrhythmia—Thiotepa—sarcoma	0.000268	0.0107	CcSEcCtD
Pseudoephedrine—ADRA2A—tendon—sarcoma	0.000268	0.00411	CbGeAlD
Pseudoephedrine—Hallucination—Vincristine—sarcoma	0.000265	0.0106	CcSEcCtD
Pseudoephedrine—Bradycardia—Mitoxantrone—sarcoma	0.000264	0.0105	CcSEcCtD
Pseudoephedrine—Delirium—Doxorubicin—sarcoma	0.000259	0.0103	CcSEcCtD
Pseudoephedrine—Tension—Thiotepa—sarcoma	0.000256	0.0102	CcSEcCtD
Pseudoephedrine—Nervousness—Thiotepa—sarcoma	0.000254	0.0101	CcSEcCtD
Pseudoephedrine—Agitation—Thiotepa—sarcoma	0.00024	0.00958	CcSEcCtD
Pseudoephedrine—Arrhythmia—Mitoxantrone—sarcoma	0.000231	0.00924	CcSEcCtD
Pseudoephedrine—SLC6A2—lymph node—sarcoma	0.000227	0.00349	CbGeAlD
Pseudoephedrine—Hypertension—Thiotepa—sarcoma	0.000225	0.009	CcSEcCtD
Pseudoephedrine—ADRA2A—testis—sarcoma	0.000222	0.0034	CbGeAlD
Pseudoephedrine—Anxiety—Thiotepa—sarcoma	0.000222	0.00885	CcSEcCtD
Pseudoephedrine—Confusional state—Thiotepa—sarcoma	0.000215	0.00858	CcSEcCtD
Pseudoephedrine—Agitation—Vincristine—sarcoma	0.000213	0.0085	CcSEcCtD
Pseudoephedrine—MAOA—lymph node—sarcoma	0.000209	0.00321	CbGeAlD
Pseudoephedrine—Vertigo—Vincristine—sarcoma	0.000208	0.00831	CcSEcCtD
Pseudoephedrine—Tachycardia—Thiotepa—sarcoma	0.000208	0.00831	CcSEcCtD
Pseudoephedrine—Anorexia—Thiotepa—sarcoma	0.000203	0.00811	CcSEcCtD
Pseudoephedrine—Anorexia—Dactinomycin—sarcoma	0.000202	0.00805	CcSEcCtD
Pseudoephedrine—Hypertension—Vincristine—sarcoma	0.0002	0.00798	CcSEcCtD
Pseudoephedrine—Hypertension—Mitoxantrone—sarcoma	0.000195	0.00778	CcSEcCtD
Pseudoephedrine—Chest pain—Mitoxantrone—sarcoma	0.000192	0.00767	CcSEcCtD
Pseudoephedrine—Anxiety—Mitoxantrone—sarcoma	0.000191	0.00764	CcSEcCtD
Pseudoephedrine—Dyspepsia—Thiotepa—sarcoma	0.000188	0.00749	CcSEcCtD
Pseudoephedrine—Confusional state—Mitoxantrone—sarcoma	0.000186	0.00741	CcSEcCtD
Pseudoephedrine—Decreased appetite—Thiotepa—sarcoma	0.000185	0.0074	CcSEcCtD
Pseudoephedrine—Decreased appetite—Dactinomycin—sarcoma	0.000184	0.00734	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Vincristine—sarcoma	0.000183	0.0073	CcSEcCtD
Pseudoephedrine—Pain—Thiotepa—sarcoma	0.000182	0.00728	CcSEcCtD
Pseudoephedrine—Pain—Dactinomycin—sarcoma	0.000181	0.00722	CcSEcCtD
Pseudoephedrine—Muscle spasms—Etoposide—sarcoma	0.00018	0.0072	CcSEcCtD
Pseudoephedrine—Anorexia—Vincristine—sarcoma	0.00018	0.00719	CcSEcCtD
Pseudoephedrine—Tachycardia—Mitoxantrone—sarcoma	0.00018	0.00717	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Mitoxantrone—sarcoma	0.000178	0.00711	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Thiotepa—sarcoma	0.000176	0.00701	CcSEcCtD
Pseudoephedrine—Anorexia—Mitoxantrone—sarcoma	0.000175	0.00701	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Dactinomycin—sarcoma	0.000174	0.00696	CcSEcCtD
Pseudoephedrine—CYP2D6—testis—sarcoma	0.000172	0.00263	CbGeAlD
Pseudoephedrine—Insomnia—Vincristine—sarcoma	0.000171	0.00683	CcSEcCtD
Pseudoephedrine—Vertigo—Etoposide—sarcoma	0.000168	0.00673	CcSEcCtD
Pseudoephedrine—Body temperature increased—Thiotepa—sarcoma	0.000168	0.00673	CcSEcCtD
Pseudoephedrine—Body temperature increased—Dactinomycin—sarcoma	0.000167	0.00668	CcSEcCtD
Pseudoephedrine—Decreased appetite—Vincristine—sarcoma	0.000164	0.00656	CcSEcCtD
Pseudoephedrine—Dyspnoea—Mitoxantrone—sarcoma	0.000164	0.00655	CcSEcCtD
Pseudoephedrine—CYP2D6—liver—sarcoma	0.000162	0.00249	CbGeAlD
Pseudoephedrine—Dyspepsia—Mitoxantrone—sarcoma	0.000162	0.00647	CcSEcCtD
Pseudoephedrine—Hypertension—Etoposide—sarcoma	0.000162	0.00647	CcSEcCtD
Pseudoephedrine—Pain—Vincristine—sarcoma	0.000162	0.00645	CcSEcCtD
Pseudoephedrine—ADRA2A—lymph node—sarcoma	0.000161	0.00246	CbGeAlD
Pseudoephedrine—Decreased appetite—Mitoxantrone—sarcoma	0.00016	0.00639	CcSEcCtD
Pseudoephedrine—Chest pain—Etoposide—sarcoma	0.00016	0.00638	CcSEcCtD
Pseudoephedrine—Pain—Mitoxantrone—sarcoma	0.000157	0.00629	CcSEcCtD
Pseudoephedrine—Confusional state—Etoposide—sarcoma	0.000154	0.00616	CcSEcCtD
Pseudoephedrine—Asthenia—Thiotepa—sarcoma	0.000153	0.00611	CcSEcCtD
Pseudoephedrine—Asthenia—Dactinomycin—sarcoma	0.000152	0.00606	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Mitoxantrone—sarcoma	0.000152	0.00606	CcSEcCtD
Pseudoephedrine—Tachycardia—Etoposide—sarcoma	0.000149	0.00597	CcSEcCtD
Pseudoephedrine—Body temperature increased—Vincristine—sarcoma	0.000149	0.00597	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Etoposide—sarcoma	0.000148	0.00591	CcSEcCtD
Pseudoephedrine—Angina pectoris—Epirubicin—sarcoma	0.000147	0.00587	CcSEcCtD
Pseudoephedrine—Anorexia—Etoposide—sarcoma	0.000146	0.00583	CcSEcCtD
Pseudoephedrine—Body temperature increased—Mitoxantrone—sarcoma	0.000145	0.00581	CcSEcCtD
Pseudoephedrine—Dysuria—Epirubicin—sarcoma	0.000141	0.00564	CcSEcCtD
Pseudoephedrine—Dizziness—Thiotepa—sarcoma	0.000141	0.00563	CcSEcCtD
Pseudoephedrine—Dyspnoea—Etoposide—sarcoma	0.000136	0.00545	CcSEcCtD
Pseudoephedrine—Angina pectoris—Doxorubicin—sarcoma	0.000136	0.00543	CcSEcCtD
Pseudoephedrine—Asthenia—Vincristine—sarcoma	0.000136	0.00542	CcSEcCtD
Pseudoephedrine—Vomiting—Thiotepa—sarcoma	0.000135	0.00541	CcSEcCtD
Pseudoephedrine—Vomiting—Dactinomycin—sarcoma	0.000134	0.00537	CcSEcCtD
Pseudoephedrine—Rash—Thiotepa—sarcoma	0.000134	0.00537	CcSEcCtD
Pseudoephedrine—Dermatitis—Thiotepa—sarcoma	0.000134	0.00536	CcSEcCtD
Pseudoephedrine—Headache—Thiotepa—sarcoma	0.000133	0.00533	CcSEcCtD
Pseudoephedrine—Rash—Dactinomycin—sarcoma	0.000133	0.00533	CcSEcCtD
Pseudoephedrine—Decreased appetite—Etoposide—sarcoma	0.000133	0.00532	CcSEcCtD
Pseudoephedrine—Asthenia—Mitoxantrone—sarcoma	0.000132	0.00527	CcSEcCtD
Pseudoephedrine—Pain—Etoposide—sarcoma	0.000131	0.00523	CcSEcCtD
Pseudoephedrine—Dysuria—Doxorubicin—sarcoma	0.000131	0.00521	CcSEcCtD
Pseudoephedrine—Sweating—Epirubicin—sarcoma	0.000129	0.00515	CcSEcCtD
Pseudoephedrine—Nausea—Thiotepa—sarcoma	0.000127	0.00506	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Etoposide—sarcoma	0.000126	0.00504	CcSEcCtD
Pseudoephedrine—Nausea—Dactinomycin—sarcoma	0.000126	0.00502	CcSEcCtD
Pseudoephedrine—Dizziness—Vincristine—sarcoma	0.000125	0.00499	CcSEcCtD
Pseudoephedrine—Bradycardia—Epirubicin—sarcoma	0.000123	0.00491	CcSEcCtD
Pseudoephedrine—Body temperature increased—Etoposide—sarcoma	0.000121	0.00483	CcSEcCtD
Pseudoephedrine—Vomiting—Vincristine—sarcoma	0.00012	0.0048	CcSEcCtD
Pseudoephedrine—Sweating—Doxorubicin—sarcoma	0.000119	0.00477	CcSEcCtD
Pseudoephedrine—Rash—Vincristine—sarcoma	0.000119	0.00476	CcSEcCtD
Pseudoephedrine—Dermatitis—Vincristine—sarcoma	0.000119	0.00475	CcSEcCtD
Pseudoephedrine—Headache—Vincristine—sarcoma	0.000118	0.00473	CcSEcCtD
Pseudoephedrine—Vomiting—Mitoxantrone—sarcoma	0.000117	0.00467	CcSEcCtD
Pseudoephedrine—Rash—Mitoxantrone—sarcoma	0.000116	0.00463	CcSEcCtD
Pseudoephedrine—Dermatitis—Mitoxantrone—sarcoma	0.000116	0.00463	CcSEcCtD
Pseudoephedrine—Headache—Mitoxantrone—sarcoma	0.000115	0.0046	CcSEcCtD
Pseudoephedrine—Bradycardia—Doxorubicin—sarcoma	0.000114	0.00454	CcSEcCtD
Pseudoephedrine—Nausea—Vincristine—sarcoma	0.000112	0.00448	CcSEcCtD
Pseudoephedrine—Asthenia—Etoposide—sarcoma	0.00011	0.00439	CcSEcCtD
Pseudoephedrine—Nausea—Mitoxantrone—sarcoma	0.000109	0.00437	CcSEcCtD
Pseudoephedrine—Arrhythmia—Epirubicin—sarcoma	0.000108	0.00431	CcSEcCtD
Pseudoephedrine—Tension—Epirubicin—sarcoma	0.000103	0.00412	CcSEcCtD
Pseudoephedrine—Nervousness—Epirubicin—sarcoma	0.000102	0.00408	CcSEcCtD
Pseudoephedrine—Dizziness—Etoposide—sarcoma	0.000101	0.00404	CcSEcCtD
Pseudoephedrine—Muscle spasms—Epirubicin—sarcoma	0.000101	0.00404	CcSEcCtD
Pseudoephedrine—Arrhythmia—Doxorubicin—sarcoma	9.98e-05	0.00399	CcSEcCtD
Pseudoephedrine—Vomiting—Etoposide—sarcoma	9.73e-05	0.00389	CcSEcCtD
Pseudoephedrine—Agitation—Epirubicin—sarcoma	9.66e-05	0.00386	CcSEcCtD
Pseudoephedrine—Rash—Etoposide—sarcoma	9.65e-05	0.00386	CcSEcCtD
Pseudoephedrine—Dermatitis—Etoposide—sarcoma	9.64e-05	0.00385	CcSEcCtD
Pseudoephedrine—Headache—Etoposide—sarcoma	9.59e-05	0.00383	CcSEcCtD
Pseudoephedrine—Tension—Doxorubicin—sarcoma	9.55e-05	0.00381	CcSEcCtD
Pseudoephedrine—Nervousness—Doxorubicin—sarcoma	9.45e-05	0.00377	CcSEcCtD
Pseudoephedrine—Vertigo—Epirubicin—sarcoma	9.45e-05	0.00377	CcSEcCtD
Pseudoephedrine—Muscle spasms—Doxorubicin—sarcoma	9.35e-05	0.00374	CcSEcCtD
Pseudoephedrine—Palpitations—Epirubicin—sarcoma	9.29e-05	0.00371	CcSEcCtD
Pseudoephedrine—Nausea—Etoposide—sarcoma	9.09e-05	0.00363	CcSEcCtD
Pseudoephedrine—Hypertension—Epirubicin—sarcoma	9.08e-05	0.00363	CcSEcCtD
Pseudoephedrine—Chest pain—Epirubicin—sarcoma	8.95e-05	0.00358	CcSEcCtD
Pseudoephedrine—Agitation—Doxorubicin—sarcoma	8.94e-05	0.00357	CcSEcCtD
Pseudoephedrine—Anxiety—Epirubicin—sarcoma	8.92e-05	0.00356	CcSEcCtD
Pseudoephedrine—Vertigo—Doxorubicin—sarcoma	8.74e-05	0.00349	CcSEcCtD
Pseudoephedrine—Confusional state—Epirubicin—sarcoma	8.65e-05	0.00346	CcSEcCtD
Pseudoephedrine—Palpitations—Doxorubicin—sarcoma	8.6e-05	0.00343	CcSEcCtD
Pseudoephedrine—Hypertension—Doxorubicin—sarcoma	8.4e-05	0.00335	CcSEcCtD
Pseudoephedrine—Tachycardia—Epirubicin—sarcoma	8.37e-05	0.00334	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Epirubicin—sarcoma	8.29e-05	0.00331	CcSEcCtD
Pseudoephedrine—Chest pain—Doxorubicin—sarcoma	8.28e-05	0.00331	CcSEcCtD
Pseudoephedrine—Anxiety—Doxorubicin—sarcoma	8.25e-05	0.0033	CcSEcCtD
Pseudoephedrine—Anorexia—Epirubicin—sarcoma	8.18e-05	0.00327	CcSEcCtD
Pseudoephedrine—Confusional state—Doxorubicin—sarcoma	8e-05	0.0032	CcSEcCtD
Pseudoephedrine—Insomnia—Epirubicin—sarcoma	7.76e-05	0.0031	CcSEcCtD
Pseudoephedrine—Tachycardia—Doxorubicin—sarcoma	7.75e-05	0.0031	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Doxorubicin—sarcoma	7.67e-05	0.00307	CcSEcCtD
Pseudoephedrine—Dyspnoea—Epirubicin—sarcoma	7.65e-05	0.00306	CcSEcCtD
Pseudoephedrine—Anorexia—Doxorubicin—sarcoma	7.57e-05	0.00302	CcSEcCtD
Pseudoephedrine—Dyspepsia—Epirubicin—sarcoma	7.55e-05	0.00302	CcSEcCtD
Pseudoephedrine—Decreased appetite—Epirubicin—sarcoma	7.46e-05	0.00298	CcSEcCtD
Pseudoephedrine—Pain—Epirubicin—sarcoma	7.34e-05	0.00293	CcSEcCtD
Pseudoephedrine—Insomnia—Doxorubicin—sarcoma	7.18e-05	0.00287	CcSEcCtD
Pseudoephedrine—Dyspnoea—Doxorubicin—sarcoma	7.08e-05	0.00283	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Epirubicin—sarcoma	7.07e-05	0.00282	CcSEcCtD
Pseudoephedrine—Dyspepsia—Doxorubicin—sarcoma	6.99e-05	0.00279	CcSEcCtD
Pseudoephedrine—Decreased appetite—Doxorubicin—sarcoma	6.9e-05	0.00276	CcSEcCtD
Pseudoephedrine—Pain—Doxorubicin—sarcoma	6.79e-05	0.00271	CcSEcCtD
Pseudoephedrine—Body temperature increased—Epirubicin—sarcoma	6.78e-05	0.00271	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Doxorubicin—sarcoma	6.54e-05	0.00261	CcSEcCtD
Pseudoephedrine—Body temperature increased—Doxorubicin—sarcoma	6.28e-05	0.00251	CcSEcCtD
Pseudoephedrine—Asthenia—Epirubicin—sarcoma	6.16e-05	0.00246	CcSEcCtD
Pseudoephedrine—Asthenia—Doxorubicin—sarcoma	5.7e-05	0.00228	CcSEcCtD
Pseudoephedrine—Dizziness—Epirubicin—sarcoma	5.67e-05	0.00227	CcSEcCtD
Pseudoephedrine—Vomiting—Epirubicin—sarcoma	5.46e-05	0.00218	CcSEcCtD
Pseudoephedrine—Rash—Epirubicin—sarcoma	5.41e-05	0.00216	CcSEcCtD
Pseudoephedrine—Dermatitis—Epirubicin—sarcoma	5.4e-05	0.00216	CcSEcCtD
Pseudoephedrine—Headache—Epirubicin—sarcoma	5.38e-05	0.00215	CcSEcCtD
Pseudoephedrine—Dizziness—Doxorubicin—sarcoma	5.25e-05	0.0021	CcSEcCtD
Pseudoephedrine—Nausea—Epirubicin—sarcoma	5.1e-05	0.00204	CcSEcCtD
Pseudoephedrine—Vomiting—Doxorubicin—sarcoma	5.05e-05	0.00202	CcSEcCtD
Pseudoephedrine—Rash—Doxorubicin—sarcoma	5.01e-05	0.002	CcSEcCtD
Pseudoephedrine—Dermatitis—Doxorubicin—sarcoma	5e-05	0.002	CcSEcCtD
Pseudoephedrine—Headache—Doxorubicin—sarcoma	4.97e-05	0.00199	CcSEcCtD
Pseudoephedrine—Nausea—Doxorubicin—sarcoma	4.72e-05	0.00188	CcSEcCtD
Pseudoephedrine—NFATC1—Disease—MDM2—sarcoma	4.49e-05	0.00044	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—MDM2—sarcoma	4.46e-05	0.000437	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	4.45e-05	0.000436	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FOXO1—sarcoma	4.43e-05	0.000434	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PDGFRB—sarcoma	4.43e-05	0.000433	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PDGFRA—sarcoma	4.36e-05	0.000427	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.35e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLCG1—sarcoma	4.35e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—IL2—sarcoma	4.35e-05	0.000426	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KDR—sarcoma	4.34e-05	0.000425	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—sarcoma	4.32e-05	0.000423	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—HRAS—sarcoma	4.31e-05	0.000422	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—JUN—sarcoma	4.23e-05	0.000414	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CTNNB1—sarcoma	4.2e-05	0.000411	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—MDM2—sarcoma	4.15e-05	0.000406	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MDM2—sarcoma	4.12e-05	0.000403	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.11e-05	0.000403	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KDR—sarcoma	4.1e-05	0.000402	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—sarcoma	4.06e-05	0.000398	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—sarcoma	4.05e-05	0.000396	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KIT—sarcoma	3.99e-05	0.000391	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CTNNB1—sarcoma	3.88e-05	0.00038	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CREB1—sarcoma	3.8e-05	0.000372	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—SRC—sarcoma	3.79e-05	0.000372	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KDR—sarcoma	3.67e-05	0.000359	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.65e-05	0.000358	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—NRAS—sarcoma	3.65e-05	0.000357	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CREB1—sarcoma	3.6e-05	0.000352	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—JUN—sarcoma	3.58e-05	0.00035	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CTNNB1—sarcoma	3.55e-05	0.000348	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—CXCR4—sarcoma	3.51e-05	0.000344	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—SRC—sarcoma	3.5e-05	0.000343	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—CXCR4—sarcoma	3.44e-05	0.000336	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KIT—sarcoma	3.38e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—NRAS—sarcoma	3.38e-05	0.000331	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NRAS—sarcoma	3.37e-05	0.00033	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP2—sarcoma	3.35e-05	0.000328	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—sarcoma	3.33e-05	0.000326	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CREB1—sarcoma	3.22e-05	0.000315	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL2—sarcoma	3.21e-05	0.000314	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—SRC—sarcoma	3.21e-05	0.000314	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—HRAS—sarcoma	3.2e-05	0.000313	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCR4—sarcoma	3.19e-05	0.000312	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MDM2—sarcoma	3.15e-05	0.000308	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KRAS—sarcoma	3.14e-05	0.000308	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MYC—sarcoma	3.14e-05	0.000307	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCR4—sarcoma	3.12e-05	0.000306	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ENO2—sarcoma	3.11e-05	0.000305	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—HBA1—sarcoma	3.09e-05	0.000303	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—NRAS—sarcoma	3.09e-05	0.000302	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—sarcoma	3.08e-05	0.000301	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—sarcoma	3.07e-05	0.000301	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—HRAS—sarcoma	2.97e-05	0.000291	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—sarcoma	2.96e-05	0.00029	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TLE1—sarcoma	2.96e-05	0.00029	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—KRAS—sarcoma	2.91e-05	0.000285	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KRAS—sarcoma	2.9e-05	0.000284	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TLE1—sarcoma	2.89e-05	0.000283	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCR4—sarcoma	2.84e-05	0.000278	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—sarcoma	2.81e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL2—sarcoma	2.81e-05	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—SRC—sarcoma	2.8e-05	0.000274	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CCND1—sarcoma	2.74e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—JUN—sarcoma	2.73e-05	0.000268	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—sarcoma	2.73e-05	0.000267	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CTNNB1—sarcoma	2.71e-05	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—sarcoma	2.7e-05	0.000264	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HRAS—sarcoma	2.67e-05	0.000261	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MDM2—sarcoma	2.66e-05	0.000261	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KRAS—sarcoma	2.66e-05	0.00026	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCR4—sarcoma	2.64e-05	0.000259	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PLCG1—sarcoma	2.64e-05	0.000258	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCR4—sarcoma	2.58e-05	0.000253	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CTNNB1—sarcoma	2.57e-05	0.000251	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—sarcoma	2.55e-05	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFC—sarcoma	2.5e-05	0.000244	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—HRAS—sarcoma	2.47e-05	0.000242	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HRAS—sarcoma	2.47e-05	0.000241	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SRC—sarcoma	2.45e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—HRAS—sarcoma	2.45e-05	0.00024	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFC—sarcoma	2.44e-05	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCR4—sarcoma	2.4e-05	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TLE1—sarcoma	2.39e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—sarcoma	2.39e-05	0.000234	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NRAS—sarcoma	2.36e-05	0.000231	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—SRC—sarcoma	2.32e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CCND1—sarcoma	2.32e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—JUN—sarcoma	2.31e-05	0.000227	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CTNNB1—sarcoma	2.3e-05	0.000225	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—HRAS—sarcoma	2.28e-05	0.000223	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—sarcoma	2.26e-05	0.000221	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HRAS—sarcoma	2.26e-05	0.000221	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NRAS—sarcoma	2.23e-05	0.000219	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TLE1—sarcoma	2.22e-05	0.000218	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MYC—sarcoma	2.2e-05	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—sarcoma	2.17e-05	0.000212	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—sarcoma	2.15e-05	0.000211	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ENO2—sarcoma	2.08e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SRC—sarcoma	2.07e-05	0.000203	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—HBA1—sarcoma	2.06e-05	0.000202	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—sarcoma	2.03e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KRAS—sarcoma	2.03e-05	0.000199	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—sarcoma	2.02e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFC—sarcoma	2.02e-05	0.000198	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NRAS—sarcoma	2e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FLT1—sarcoma	1.99e-05	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PLCG1—sarcoma	1.96e-05	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FLT1—sarcoma	1.95e-05	0.000191	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—KRAS—sarcoma	1.92e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PLCG1—sarcoma	1.92e-05	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCR4—sarcoma	1.88e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFC—sarcoma	1.88e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ATF1—sarcoma	1.86e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MYC—sarcoma	1.86e-05	0.000182	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCR4—sarcoma	1.84e-05	0.00018	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ATF1—sarcoma	1.82e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—sarcoma	1.82e-05	0.000178	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—sarcoma	1.81e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLCG1—sarcoma	1.76e-05	0.000173	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HRAS—sarcoma	1.73e-05	0.000169	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KRAS—sarcoma	1.72e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CREB1—sarcoma	1.71e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CREB1—sarcoma	1.67e-05	0.000164	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL2—sarcoma	1.65e-05	0.000162	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HRAS—sarcoma	1.63e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FLT1—sarcoma	1.61e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLCG1—sarcoma	1.59e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—sarcoma	1.53e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCR4—sarcoma	1.52e-05	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ATF1—sarcoma	1.51e-05	0.000148	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FLT1—sarcoma	1.5e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLCG1—sarcoma	1.47e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1R—sarcoma	1.46e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HRAS—sarcoma	1.46e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SRC—sarcoma	1.44e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1R—sarcoma	1.43e-05	0.00014	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCR4—sarcoma	1.42e-05	0.000139	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—sarcoma	1.41e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ATF1—sarcoma	1.4e-05	0.000137	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FOXO1—sarcoma	1.39e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL2—sarcoma	1.39e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDGFRB—sarcoma	1.39e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—NRAS—sarcoma	1.39e-05	0.000136	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CREB1—sarcoma	1.38e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDGFRA—sarcoma	1.37e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FOXO1—sarcoma	1.36e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL2—sarcoma	1.36e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDGFRB—sarcoma	1.36e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ENO2—sarcoma	1.35e-05	0.000133	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—HBA1—sarcoma	1.35e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDGFRA—sarcoma	1.34e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CREB1—sarcoma	1.28e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—sarcoma	1.26e-05	0.000124	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—sarcoma	1.24e-05	0.000121	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KRAS—sarcoma	1.2e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1R—sarcoma	1.18e-05	0.000116	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KDR—sarcoma	1.15e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLCG1—sarcoma	1.15e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KDR—sarcoma	1.13e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FOXO1—sarcoma	1.13e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—sarcoma	1.13e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFRB—sarcoma	1.12e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFRA—sarcoma	1.11e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1R—sarcoma	1.1e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—sarcoma	1.06e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KIT—sarcoma	1.06e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—NRAS—sarcoma	1.06e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FOXO1—sarcoma	1.05e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—sarcoma	1.05e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFRB—sarcoma	1.04e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KIT—sarcoma	1.04e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—NRAS—sarcoma	1.04e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFRA—sarcoma	1.03e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—sarcoma	1.02e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—HRAS—sarcoma	1.02e-05	9.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CREB1—sarcoma	1.01e-05	9.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CREB1—sarcoma	9.87e-06	9.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—sarcoma	9.66e-06	9.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—sarcoma	9.49e-06	9.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—sarcoma	9.45e-06	9.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—sarcoma	9.31e-06	9.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—sarcoma	9.12e-06	8.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—sarcoma	8.93e-06	8.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—sarcoma	8.65e-06	8.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KIT—sarcoma	8.58e-06	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—NRAS—sarcoma	8.58e-06	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MDM2—sarcoma	8.35e-06	8.18e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MDM2—sarcoma	8.17e-06	8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CREB1—sarcoma	8.16e-06	8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KIT—sarcoma	7.97e-06	7.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—NRAS—sarcoma	7.97e-06	7.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—sarcoma	7.81e-06	7.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—HRAS—sarcoma	7.76e-06	7.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—HRAS—sarcoma	7.59e-06	7.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CREB1—sarcoma	7.59e-06	7.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—sarcoma	7.46e-06	7.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—sarcoma	7.38e-06	7.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—sarcoma	7.3e-06	7.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CCND1—sarcoma	7.27e-06	7.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—sarcoma	7.26e-06	7.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JUN—sarcoma	7.26e-06	7.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CTNNB1—sarcoma	7.2e-06	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CCND1—sarcoma	7.11e-06	6.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JUN—sarcoma	7.1e-06	6.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CTNNB1—sarcoma	7.04e-06	6.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—sarcoma	6.86e-06	6.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MDM2—sarcoma	6.76e-06	6.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SRC—sarcoma	6.51e-06	6.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SRC—sarcoma	6.37e-06	6.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—sarcoma	6.34e-06	6.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MDM2—sarcoma	6.28e-06	6.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—HRAS—sarcoma	6.27e-06	6.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NRAS—sarcoma	6.26e-06	6.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—sarcoma	6.2e-06	6.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NRAS—sarcoma	6.13e-06	6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—sarcoma	6.04e-06	5.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CCND1—sarcoma	5.88e-06	5.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUN—sarcoma	5.87e-06	5.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—sarcoma	5.83e-06	5.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—HRAS—sarcoma	5.83e-06	5.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CTNNB1—sarcoma	5.83e-06	5.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—sarcoma	5.71e-06	5.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—sarcoma	5.71e-06	5.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—sarcoma	5.61e-06	5.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—sarcoma	5.58e-06	5.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CCND1—sarcoma	5.47e-06	5.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUN—sarcoma	5.46e-06	5.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CTNNB1—sarcoma	5.41e-06	5.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—sarcoma	5.39e-06	5.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—sarcoma	5.27e-06	5.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SRC—sarcoma	5.27e-06	5.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—sarcoma	5.13e-06	5.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NRAS—sarcoma	5.07e-06	4.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SRC—sarcoma	4.89e-06	4.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—sarcoma	4.79e-06	4.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—sarcoma	4.77e-06	4.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—sarcoma	4.72e-06	4.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NRAS—sarcoma	4.71e-06	4.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—sarcoma	4.69e-06	4.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—sarcoma	4.62e-06	4.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HRAS—sarcoma	4.58e-06	4.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HRAS—sarcoma	4.48e-06	4.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—sarcoma	4.39e-06	4.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—sarcoma	4.36e-06	4.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—sarcoma	4.29e-06	4.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—sarcoma	4.05e-06	3.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—sarcoma	3.88e-06	3.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HRAS—sarcoma	3.71e-06	3.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—sarcoma	3.6e-06	3.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HRAS—sarcoma	3.44e-06	3.37e-05	CbGpPWpGaD
